NECA in the Know

This week, we're sitting down with John Faragon to talk about the latest in COVID-19 vaccine information. Tune in to learn about what's going on with the Johnson & Johnson vaccine, how many doses people need to be considered fully vaccinated, and more.   -- Help us track the number of listeners our episode gets by filling out this brief form!  (https://www.e2NECA.org/?r=AQX7941) -- W...

This week, we're sitting down with John Faragon for the second part of our series on the CROI 2022 conference. Find out about some of the latest HIV studies, medications, and advancements from this year's event.   -- Help us track the number of listeners our episode gets by filling out this brief form!  (https://www.e2NECA.org/?r=AQX7941) -- Want to chat? Email us at podcast@necaaetc.org...

This week, we're sitting down with John Faragon to get an update on the latest regarding the ever-changing COVID-19 pandemic. Where do we stand now in terms of cases, recommendations on masking, vaccination, and more? Tune in to find out.   -- Help us track the number of listeners our episode gets by filling out this brief form!  (https://www.e2NECA.org/?r=AQX7941) -- Want to chat? Email us a...

This week, we're sitting down with John Faragon for part one of our two-part series on the CROI 2022 conference. Find out what this conference is, why it's so important for HIV providers, and everything that was covered this year.    -- Help us track the number of listeners our episode gets by filling out this brief form!  (https://www.e2NECA.org/?r=AQX7941) -- Want to chat? Email us at...

This week, we're sitting down with John Faragon to talk about diagnostic testing for SARS-CoV2, or COVID-19. Learn more about how to determine when to test, which test to use, and why it all matters.  -- Help us track the number of listeners our episode gets by filling out this brief form!  (https://www.e2NECA.org/?r=AQX7941) -- Want to chat? Email us at podcast@necaaetc.org with comments or...

This week, we're sitting down with John Faragon to talk about the NIH guidelines for outpatient management of COVID-19.  -- Help us track the number of listeners our episode gets by filling out this brief form!  (https://www.e2NECA.org/?r=AQX7941) -- Want to chat? Email us at podcast@necaaetc.org with comments or ideas for new episodes.  -- Check out our free online courses: www.necaaetc.org/...

This week, we sit down with John Faragon to discuss a new HIV variant  - what it is, how it came about, and what it means.  -- Help us track the number of listeners our episode gets by filling out this brief form!  (https://www.e2NECA.org/?r=AQX7941) -- Want to chat? Email us at podcast@necaaetc.org with comments or ideas for new episodes.  -- Check out our free online courses: www.necaaetc.org/ri...

This week, we sat down with John Faragon to talk about the approval to use cabotegravir for HIV prevention. Learn all about this injection, who it's for, and how it can be used for pre-exposure prophylaxis or PrEP.  -- Help us track the number of listeners our episode gets by filling out this brief form!  (https://www.e2NECA.org/?r=AQX7941) -- Want to chat? Email us at podcast@necaaetc.org wi...

This week, we’re sitting down with John Faragon to talk a little bit about anti-retroviral therapy for folks with a history of treatment failure and resistance.  -- Help us track the number of listeners our episode gets by filling out this brief form!  (https://www.e2NECA.org/?r=AQX7941) -- Want to chat? Email us at podcast@necaaetc.org with comments or ideas for new episodes.  -- Check out our fr...

This week, we’re sitting down with Dr. Marshall Glesby to talk a little bit an exciting advancement in HIV medicine – a new clinical trial for an HIV vaccine using mRNA technology.  -- Help us track the number of listeners our episode gets by filling out this brief form!  (https://www.e2NECA.org/?r=AQX7941) -- Want to chat? Email us at podcast@necaaetc.org with comments or ideas for new episodes. ...

This week, we're sitting down with Dr. Grant Ellsworth to talk about a recent study regarding prevention of anal cancer and why it’s important for people living with HIV.  -- Help us track the number of listeners our episode gets by filling out this brief form!  (https://www.e2NECA.org/?r=AQX7941) -- Want to chat? Email us at podcast@necaaetc.org with comments or ideas for new episodes.  -- C...

Today, we’re sitting down with Dr. Marshall Glesby for a special edition episode to talk about an exciting advancement in HIV medicine – a third person has achieved long-term remission of HIV by means of a stem cell transplant.  Learn about how his team contributed to this study and what this means for the future of HIV medicine.  -- Help us track the number of listeners our episode gets by fillin...

This week, we're chatting with John Faragon about the role of monoclonal antibodies in the omicron variant of COVID-19.  Find out how they can help not only fight against the virus, but prevent folks from getting infected, and who would benefit most from this treatment. -- Help us track the number of listeners our episode gets by filling out this brief form!  (https://www.e2NECA.org/?r=AQX794...

This week on NECA in the Know, we're introducing four new mobile apps for drug interactions that John Faragon has developed with NECA AETC. Learn all about what they are, who they're for, how they work, and more. Download all four apps from the Google Play Store ( https://cutt.ly/lOEy9iP ) or the Apple App Store ( https://cutt.ly/5PSFFHq ) today. -- Help us track the number of listeners...

This week,  we’re sitting down with John Faragon to talk a little more about Paxlovid – a drug used to treat COVID-19. We dive into what exactly it is, how providers should prescribe it, and more.  -- Help us track the number of listeners our episode gets by filling out this brief form!  (https://www.e2NECA.org/?r=AQX7941) -- Want to chat? Email us at podcast@necaaetc.org with comments or ideas fo...

This week, we're back with John Faragon to break down the use of lenacapavir for HIV infection. Find out what this medication is, who it's for, and how it can help treatment experienced patients.  -- Help us track the number of listeners our episode gets by filling out this brief form!  (https://www.e2NECA.org/?r=AQX7941) -- Want to chat? Email us at podcast@necaaetc.org with comments or...

This week we're back for a quick round-up with John Faragon to talk about the use of two medications to treat HIV – islatravir and doravirine. Find out what they are, what they do, and how they can help you as a provider improve treatment for PLWH.  -- Help us track the number of listeners our episode gets by filling out this brief form!  (https://www.e2NECA.org/?r=AQX7941) -- Want to chat? E...

Happy New Year! We're kicking off our 2022 podcast season with an update on HIV stats from the CDC. We break it all down with John Faragon so that you as providers can know what these new numbers mean and how they affect PLWH.  -- Help us track the number of listeners our episode gets by filling out this brief form!  (https://www.e2NECA.org/?r=AQX7941) -- Want to chat? Email us at podcast@nec...

In this episode, Marianna & John discuss a crucial topic in the COVID-19 pandemic saga - mixing & matching COVID-19 vaccine booster shots. Is it recommended? Is it safe? Listen to learn all this and more. -- Help us track the number of listeners our episode gets by filling out this brief form!  (https://www.e2NECA.org/?r=AQX7941) -- Want to chat? Email us at podcast@necaaetc.org with comme...

This week on the podcast, we’re back with John Faragon to talk about Paxlovid – an oral antiviral treatment from Pfizer for COVID-19. Find out what it is, who it's for, how it was developed, and more.  -- Help us track the number of listeners our episode gets by filling out this brief form!  (https://www.e2NECA.org/?r=AQX7941) -- Want to chat? Email us at podcast@necaaetc.org with comments or...

This week, John Faragon sits down with us for a special edition episode all about the latest COVID-19 variant - Omicron. Learn about what it is, when it was first discovered, who is at risk, and more.  -- Help us track the number of listeners our episode gets by filling out this brief form!  (https://www.e2NECA.org/?r=AQX7941) -- Want to chat? Email us at podcast@necaaetc.org with comments or idea...

This week, we're back from our Thanksgiving break to talk all things fostemsavir, a new HIV medication. What is it? Who is it for? What do providers need to know? John Faragon breaks it all down for us, so listen to learn all this and more.  -- Help us track the number of listeners our episode gets by filling out this brief form!  (https://www.e2NECA.org/?r=AQX7941) -- Want to chat? Email us...

This week, we're sitting down with John Faragon to discuss a hot topic in the COVID-19 pandemic saga - mixing & matching COVID-19 vaccine booster shots. Is it recommended? Is it safe?  Listen to learn all this and more.  -- Help us track the number of listeners our episode gets by filling out this brief form!  (https://www.e2NECA.org/?r=AQX7941) -- Want to chat? Email us at podcast@necaae...

This week, we're talking to John Faragon about the side effect of weight gain as a result of certain HIV medications. Find out which medications to look out for, what providers are seeing in some patients, and the guidance to address this.   -- Help us track the number of listeners our episode gets by filling out this brief form!  (https://www.e2NECA.org/?r=AQX7941) -- Want to chat? Email us...

This week, we're sitting down with John Faragon to talk all things Molnupiravir. Find out what this new investigational medication for COVID-19 is, who it's for, and what it means for the ongoing pandemic.  -- Help us track the number of listeners our episode gets by filling out this brief form!  (https://www.e2NECA.org/?r=AQX7941) -- Want to chat? Email us at podcast@necaaetc.org with c...